Student or educator? Sign up with your school email and get 6 months of Pro free.

The DOI matches its Crossref record; 41 of the 44 references it cites were found in a registry or an index.

Addressing the burden of mental, neurological, and substance use disorders: key messages from Disease Control Priorities, 3rd edition

Open access

Abstract

The burden of mental, neurological, and substance use (MNS) disorders increased by 41% between 1990 and 2010 and now accounts for one in every 10 lost years of health globally. This sobering statistic does not take into account the substantial excess mortality associated with these disorders or the social and economic consequences of MNS disorders on affected persons, their caregivers, and society. A wide variety of effective interventions, including drugs, psychological treatments, and social interventions, can prevent and treat MNS disorders. At the population-level platform of service delivery, best practices include legislative measures to restrict access to means of self-harm or suicide and to reduce the availability of and demand for alcohol. At the community-level platform, best practices include life-skills training in schools to build social and emotional competencies. At the health-care-level platform, we identify three delivery channels. Two of these delivery channels are especially relevant from a public health perspective: self-management (eg, web-based psychological therapy for depression and anxiety disorders) and primary care and community outreach (eg, non-specialist health worker delivering psychological and pharmacological management of selected disorders). The third delivery channel, hospital care, which includes specialist services for MNS disorders and first-level hospitals providing other types of services (such as general medicine, HIV, or paediatric care), play an important part for a smaller proportion of cases with severe, refractory, or emergency presentations and for the integration of mental health care in other health-care channels, respectively. The costs of providing a significantly scaled up package of specified cost-effective interventions for prioritised MNS disorders in low-income and lower-middle-income countries is estimated at US$3-4 per head of population per year. Since a substantial proportion of MNS disorders run a chronic and disabling course and adversely affect household welfare, intervention costs should largely be met by government through increased resource allocation and financial protection measures (rather than leaving households to pay out-of-pocket). Moreover, a policy of moving towards universal public finance can also be expected to lead to a far more equitable allocation of public health resources across income groups. Despite this evidence, less than 1% of development assistance for health and government spending on health in low-income and middle-income countries is allocated to the care of people with these disorders. Achieving the health gains associated with prioritised interventions will require not just financial resources, but committed and sustained efforts to address a range of other barriers (such as paucity of human resources, weak governance, and stigma). Ultimately, the goal is to massively increase opportunities for people with MNS disorders to access services without the prospect of discrimination or impoverishment and with the hope of attaining optimal health and social outcomes.

Overview

Integrity signals

Registry

Crossref · 10.1016/s0140-6736(15)00390-6

Cites

41 of 41 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

The text we found for this paper looks like another document, so its claims and self-check weren’t run. The registry and citation checks still apply.

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The text we found for this paper looks like another document, so the self-check wasn’t run.

Citations

Cites

Show all 44 references

Cited by

See all 889

Metadata

Authors
Patel, V., Chisholm, D., Parikh, R., Charlson, F. J., Degenhardt, L., Dua, T., Ferrari, A. J., Hyman, S., Laxminarayan, R., Levin, C., Lund, C., Medina Mora, M. E., Petersen, I., Scott, J., Shidhaye, R., Vijayakumar, L., Thornicroft, G., & Whiteford, H.
Affiliations
  • London School of Hygiene & Tropical Medicine (GB)
  • World Health Organization (CH)
  • Public Health Foundation of India (IN)
  • The University of Queensland (AU)
  • The University of Melbourne (AU)
  • Broad Institute (US)
  • Center for Disease Dynamics, Economics & Policy (US)
  • University of Washington (US)
  • University of Cape Town (ZA)
  • University of KwaZulu-Natal (ZA)
  • Maastricht University (NL)
  • King's College London (GB)
Corresponding author
Patel, Vikram
Venue
The Lancet
Publisher
Elsevier BV
Published
2016-04
Volume
387
Issue
10028
Pages
1672-1685
ISSN
  • 0099-5355 (ISSN-L)
  • 0140-6736
OpenAlex
W1922178820
Cited by
889
References
44
Citations by year
2026: 66 · 2025: 109 · 2024: 85 · 2023: 105 · 2022: 99 · 2021: 136 · 2020: 63 · 2019: 62 · 2018: 58 · 2017: 58 · 2016: 46
FWCI
8.48
Type
journal article
Language
en
Open access
Licence
Locations
  • The Lancet (acceptedVersion)
  • PubMed (publishedVersion)
  • Research Publications (Maastricht University) (publishedVersion, other-oa)
  • LSHTM Research Online (London School of Hygiene and Tropical Medicine) (acceptedVersion)
  • Research Portal (King's College London) (submittedVersion)
  • Research Publications (Maastricht University) (submittedVersion, other-oa)
Funders
  • European Union Seventh Framework Programme (FP7/2007-2013)
  • Australian National Health and Medical Research Council principal research fellowship (#1041472)
Topics
  • Health Sciences › Medicine › Psychiatry and Mental health › Mental Health Treatment and Access
  • Social Sciences › Economics, Econometrics and Finance › Economics and Econometrics › Health Systems, Economic Evaluations, Quality of Life
  • Social Sciences › Psychology › Clinical Psychology › Psychiatric care and mental health services
Keywords
mental, neurological and substance use disorders, global burden of disease, suicide prevention, alcohol availability restrictions, non-specialist health workers, primary care, hospital care, mental health funding, health policy, stigma, low- and middle-income countries, cost-effectiveness
MeSH terms
Mental Disorders, Delivery of Health Care, Humans, Nervous System Diseases, Global Health, Health Care Costs, Cost of Illness, Universal Health Insurance, Substance-Related Disorders

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Addressing the burden of mental, neurological, and substance use disorders: key messages from Disease Control Priorities, 3rd edition. https://app.cochat.ai/papers/10.1016/s0140-6736(15)00390-6
The paper
Patel, V., Chisholm, D., Parikh, R., Charlson, F. J., Degenhardt, L., Dua, T., Ferrari, A. J., Hyman, S., Laxminarayan, R., Levin, C., Lund, C., Medina Mora, M. E., Petersen, I., Scott, J., Shidhaye, R., Vijayakumar, L., Thornicroft, G., & Whiteford, H. (2016). Addressing the burden of mental, neurological, and substance use disorders: key messages from Disease Control Priorities, 3rd edition. The Lancet. https://doi.org/10.1016/s0140-6736(15)00390-6

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.